文献速递血脂与心血管预防

ACC/AHA汇总队列心血管风险方程在临床实践中的表现

Performance of the ACC/AHA Pooled Cohort Cardiovascular Risk Equations in Clinical Practice.
PubMed 文献 · J Am Coll Cardiol · 2023-01-01

该研究在1997-2000年明尼苏达州奥姆斯特德县连续基层就诊的30,042名成人中验证ACC/AHA汇总队列方程(PCE)预测动脉粥样硬化性心血管疾病(ASCVD)的性能,随访至2016年。结果显示PCE整体表现良好(c统计量0.78),超出PCE范围的值和他汀起始治疗不影响模型性能。

要点

  • PCE在真实临床实践社区队列中整体区分度良好,c统计量为0.78。
  • 非白人女性c统计量最高(0.81),白人男性最低(0.77)。
  • 超出PCE范围的值及随访中起始他汀治疗未影响模型性能。

核心结论

  • PCE在代表真实临床实践的社区队列中表现良好,超出PCE范围的值和他汀起始治疗不影响其性能。

研究设计与样本

  • 研究在1997至2000年间于明尼苏达州奥姆斯特德县连续招募寻求初级保健的患者,随访至2016年,纳入标准与PCE推导相似。
  • 共纳入30,042名成人,平均年龄48.5±12.2岁,46%为男性,中位随访16.5年(分析截尾至10年)。

主要发现

  • 平均ASCVD风险为5.6%±8.73%,共发生1,555例ASCVD事件(5.2%)。
  • PCE整体c统计量为0.78,在性别和种族亚组中表现良好;非白人女性c统计量最高(0.81),白人男性最低(0.77)。
  • 超出PCE范围的值和他汀药物起始治疗未影响模型性能。

临床怎么用

  • 在真实临床实践中,PCE可用于预测ASCVD风险,其区分度在不同性别和种族亚组中均较好。
  • 即使患者年龄、血压或胆固醇值超出PCE推导范围,或随访中起始他汀治疗,PCE仍可保持预测性能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The performance of the American College of Cardiology/American Heart Association pooled cohort equation (PCE) for atherosclerotic cardiovascular disease (ASCVD) in real-world clinical practice has not been evaluated extensively. OBJECTIVES: The goal of this study was to test the performance of PCE to predict ASCVD risk in the community, and determine if including individuals with values outside the PCE range (ie, age, blood pressure, cholesterol) or statin therapy initiation over follow-up would significantly affect PCE predictive capabilities. METHODS: The PCE was validated in a community-based cohort of consecutive patients who sought primary care in Olmsted County, Minnesota, between 1997 and 2000, followed-up through 2016. Inclusion criteria were similar to those of PCE derivation. Patient information was ascertained by using the record linkage system of the Rochester Epidemiology Project. ASCVD events (nonfatal and fatal myocardial infarction and ischemic stroke) were validated in duplicate. Calculated and observed ASCVD risk and c-statistics were compared across predefined groups. RESULTS: This study included 30,042 adults, with a mean age of 48.5 ± 12.2 years; 46% were male. Median follow-up was 16.5 years, truncated at 10 years for this analysis. Mean ASCVD risk was 5.6% ± 8.73%. There were 1,555 ASCVD events (5.2%). The PCE revealed good performance overall (c-statistic 0.78) and in sex and race subgroups; it was highest among non-White female subjects (c-statistic 0.81) and lowest in White male subjects (c-statistic 0.77). Out-of-range values and initiation of statin medication did not affect model performance. CONCLUSIONS: The PCE performed well in a community cohort representing real-world clinical practice. Values outside PCE ranges and initiation of statin medication did not affect performance. These results have implications for the applicability of current strategies for the prevention of ASCVD.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Medina-Inojosa JR, Somers VK, Garcia M, et al. Performance of the ACC/AHA Pooled Cohort Cardiovascular Risk Equations in Clinical Practice. J Am Coll Cardiol. 2023. PMID: 37793746. doi:10.1016/j.jacc.2023.07.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。